Abstract
This cross-sectional study examines the use of telemedicine for buprenorphine inductions among individuals with commercial insurance or Medicare Advantage during the temporary repeal of the Ryan Haight Act requirement of in-person evaluation before prescribing buprenorphine during to the COVID-19 pandemic.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Buprenorphine / therapeutic use*
-
COVID-19*
-
Cross-Sectional Studies
-
Drug Prescriptions*
-
Female
-
Humans
-
Insurance Coverage
-
Legislation, Medical
-
Male
-
Medicare Part C
-
Middle Aged
-
Narcotic Antagonists / therapeutic use
-
Opioid-Related Disorders / drug therapy*
-
Pandemics*
-
Practice Patterns, Physicians' / legislation & jurisprudence*
-
Telemedicine / legislation & jurisprudence*
-
United States
-
Young Adult
Substances
-
Narcotic Antagonists
-
Buprenorphine